Antiplatelet Therapy in AMI and Cardiogenic Shock: National Cardiogenic Shock Initiative
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Abiomed; Boston Scientific Corporation; Chiesi; Saranas; Zoll